Lifetime Cancer Risk Is High in Unaffected Postmenopausal BRCA Carriers

Elsevier Global Medical News. 2008 Jan 3, B. Jancin

SAN ANTONIO (EGMN) - Postmenopausal women with no personal history of cancer who are found to be BRCA mutation carriers face very high and yet largely underappreciated risks of breast and ovarian cancer during their remaining life span, Dr. Jeffrey Tice reported at the San Antonio Breast Cancer Symposium.Indeed, the lifetime risks of breast cancer and ovarian cancer are roughly 50% in a 55-year-old woman with a BRCA1 or BRCA2 mutation, according to Dr. Tice of the University of California, San Francisco.Most...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Meet Our Experts

Meet our Advisory and Editorial Boards comprised of physician editors and world-renowned experts.

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration